Oxford Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$835K	Buy	+14,777	New	+$862K	0.36%	66
2025 Q4	–	Sell	-10,426	Closed	-$565K	–	520
2025 Q3	$565K	Sell	10,426 -14,310	-58%	-$818K	0.19%	167
2025 Q2	$1.36M	Buy	+24,736	New	+$1.46M	0.45%	37
2019 Q3	–	Sell	-61,908	Closed	-$5.3M	–	1717
2019 Q2	$5.3M	Buy	+61,908	New	+$5.3M	0.11%	215
2018 Q4	–	Sell	-11,492	Closed	-$1.12M	–	1789
2018 Q3	$1.12M	Buy	11,492 +188	+2%	+$18.8K	0.02%	953
2018 Q2	$1.06M	Buy	+11,304	New	+$990K	0.02%	1011
2018 Q1	–	Sell	-9,629	Closed	-$859K	–	1620
2017 Q4	$859K	Buy	9,629 +4,780	+99%	+$416K	0.02%	996
2017 Q3	$452K	Buy	+4,849	New	+$428K	0.01%	1230
2015 Q2	–	Sell	-10,672	Closed	-$1.33M	–	668
2015 Q1	$1.33M	Sell	10,672 -23,282	-69%	-$2.47M	0.03%	418
2014 Q4	$3.13M	Buy	+33,954	New	+$2.82M	0.07%	279